Holen Sie sich die Stockscreener-App
1.19
0.83%
-0.01
Vorhandelsmarkt:
1.20
0.01
+0.84%
Lucid Diagnostics Inc Aktie (LUCD) Neueste Nachrichten
Lucid Diagnostics Inc. (LUCD) Stock Rises on Q4 2025 Earnings - Quiver Quantitative
Lucid Diagnostics 2025 10-K: Revenue $4.7M, Net Loss $58.0M - TradingView
Lucid Diagnostics (NASDAQ: LUCD) flags going-concern risk while advancing EsoGuard strategy - Stock Titan
Lucid Diagnostics Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
What To Expect From Lucid Diagnostics Inc (LUCD) Q4 2025 Earnings - GuruFocus
Ideas Watch: Can Lucid Diagnostics Inc lead its sector in growth2026 Trading Volume Trends & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
Lucid Diagnostics Inc expected to post a loss of 10 cents a shareEarnings Preview - TradingView
Lucid Diagnostics Inc. (NASDAQ:LUCD) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Portfolio Shifts: Can Lucid Diagnostics Inc beat the S P 5002026 Breakouts & Risk Managed Investment Strategies - baoquankhu1.vn
If You Invested $1,000 in Lucid Diagnostics Inc. (LUCD) - Stock Titan
DarioHealth Corp. (DRIO) Posts Fourth Quarter Loss, Surpasses Revenue Projections - Bitget
Lucid Diagnostics (LUCD) Expected to Announce Earnings on Thursday - MarketBeat
Inogen (INGN) soars 6.6%: Is further upside left in the stock? - MSN
Lucid Diagnostics dips after pricing $25M stock offering - MSN
PAVmed executives to outline 2025 strategy, Q4 results on March 30 call - Stock Titan
2,960,066 Shares in Lucid Diagnostics Inc. $LUCD Acquired by Ghisallo Capital Management LLC - MarketBeat
Lucid Diagnostics (NASDAQ:LUCD) Cut to "Sell" at Wall Street Zen - MarketBeat
LUCD SEC FilingsLucid Diagnostics Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Lucid Diagnostics to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 26, 2026 - Sahm
Decliners Report: Whats the MACD signal for Lucid Diagnostics Inc2026 Volume & Long Hold Capital Preservation Tips - baoquankhu1.vn
Lucid Diagnostics CEO to detail growth strategy in March 26 call - Stock Titan
Price Action: What is the next catalyst for Lucid Diagnostics IncJuly 2025 Catalysts & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Risk Recap: What is the next catalyst for Lucid Diagnostics IncJuly 2025 Sector Moves & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Breakouts Watch: Can Lucid Diagnostics Inc expand into new marketsVolume Spike & Weekly Momentum Stock Picks - baoquankhu1.vn
LUCD Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
908 Devices Inc. (MASS) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Lucid Diagnostics (NASDAQ:LUCD) Upgraded to “Hold” at Wall Street Zen - Defense World
Lucid Diagnostics (NASDAQ:LUCD) Upgraded to "Hold" at Wall Street Zen - MarketBeat
LUCD Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Lucid Diagnostics Inc. (NASDAQ:LUCD) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Downgrade Watch: Is Lucid Diagnostics Inc likely to announce a buybackDay Trade & Real-Time Chart Breakout Alerts - baoquankhu1.vn
Lucid Diagnostics CEO granted 2.17M restricted shares | LUCD SEC FilingForm 4 - Stock Titan
Director at Lucid Diagnostics (LUCD) receives 123,000-share restricted stock grant - Stock Titan
123K-share equity grant to Lucid Diagnostics (LUCD) director Debra White vests 2029 - Stock Titan
Lucid director granted 123,000 restricted shares | LUCD SEC FilingForm 4 - Stock Titan
Director at Lucid Diagnostics (LUCD) awarded 123,000 restricted shares - Stock Titan
Director at Lucid Diagnostics (LUCD) granted 123K restricted shares - Stock Titan
[Form 4] Lucid Diagnostics Inc. Insider Trading Activity - Stock Titan
Director at Lucid Diagnostics (NASDAQ: LUCD) receives 123,000-share restricted stock grant - Stock Titan
Lucid Diagnostics (LUCD) CFO granted 470,000 restricted shares vesting in 2029 - Stock Titan
Lucid Diagnostics (LUCD) COO awarded 620,000 restricted shares in Form 4 filing - Stock Titan
Lucid Diagnostics (LUCD) awards 300,000 restricted shares to General Counsel - Stock Titan
Aberdeen Group plc Invests $2.53 Million in Lucid Diagnostics Inc. $LUCD - MarketBeat
Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results - Intellectia AI
Aug Decliners: Is Lucid Diagnostics Inc likely to announce a buybackJuly 2025 Price Swings & Stepwise Swing Trade Plans - baoquankhu1.vn
What’s the fair value of Lucid Diagnostics Inc. stock2025 Winners & Losers & Low Risk High Reward Ideas - mfd.ru
Surprises Report: Can Lucid Diagnostics Inc be recession proofWeekly Trade Review & Precise Trade Entry Recommendations - baoquankhu1.vn
Will Lucid Diagnostics Inc. stock remain a Wall Street favoriteQuarterly Market Summary & AI Powered Buy/Sell Recommendations - mfd.ru
Lucid Diagnostics Inc. (NASDAQ:LUCD) Short Interest Update - MarketBeat
Can Lucid Diagnostics Inc. lead its sector in growthWeekly Loss Report & Safe Entry Point Identification - mfd.ru
Earnings Miss: Is Lucid Diagnostics Inc showing insider buying2025 Volume Leaders & Weekly Watchlist of Top Performers - baoquankhu1.vn
Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard® - Eastern Progress
PAVmed wipes out legacy convertibles in $45M balance-sheet reset - Stock Titan
Stock Analysis: What is Lucid Diagnostics Incs valuation compared to sector2025 Growth vs Value & Daily Chart Pattern Signals - baoquankhu1.vn
Lucid Diagnostics Inc. (NASDAQ:LUCD) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Lucid Diagnostics Inc. (NASDAQ:LUCD) Short Interest Down 20.0% in January - MarketBeat
Lucid Diagnostics inks deal with VA to use esophageal cancer screen - Crain's New York Business
Is Lucid Diagnostics Inc. gaining market share2025 Technical Overview & Fast Exit and Entry Strategy Plans - mfd.ru
Revenue Check: Is Corvus Pharmaceuticals Inc a stock for growth or value investorsWeekly Profit Summary & AI Based Buy and Sell Signals - baoquankhu1.vn
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025 - Quantisnow
Lucid Diagnostics: Green Flags, But Dilution And Friction Keep Me Neutral (LUCD) - Seeking Alpha
Perkins Capital Management Inc. Invests $1.14 Million in Lucid Diagnostics Inc. $LUCD - MarketBeat
1.53%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):